ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Zein-Ceria Hybrid Microparticles Enable Long-Term ROS-Scavenging Oxygenation for Osteogenic Microtissues Engineering.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Oxygen- and biological cue-deprived microenvironments formed during tissue regeneration severely limit cell survival and differentiation, resulting in long-term structural and functional deficits. However, conventional oxygen-releasing biomaterials often exhibit burst releases, with the vast majority of oxygen released during the first few days, which is associated with high levels of concomitant reactive oxygen species (ROS)-derived oxidative stress and a lack of bioactive factors. Here, we report a hierarchically engineered zein-ceria hybrid microparticle that enables sustained ROS-neutral oxygenation for over 40 days and supplies an osteoinductive factor. A hydrophobic zein core stabilizes the oxygen source and suppresses burst release, while a ceria nanozyme-integrated shell continuously scavenges excess ROS via redox cycling. Biocompatible surface engineering enables the seamless integration of these microparticles within stem cell spheroids, which markedly enhances cell survival under anoxia. Their biofunctional surface supports enzymatic protein immobilization under physiological conditions, enabling spontaneous osteogenesis of engineered bone microtissues. In a severely oxygen-deprived mouse calvarial defect model, the engineered microtissues accelerated bone regeneration. Our biomaterial design enables control of burst oxygen release, ROS modulation, and growth factor release, built on a zein-ceria double-layer architecture, offering a modular platform that broadens the utility of oxygenating and bioactive micromaterials in regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.